Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chester V Oddis, MD
University of Pittsburgh Department of Medicine/Division of Rheumatology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
54 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospital "kaspela" Rheumatology Clinic
Plovdiv, Bulgaria
- Umhat "st. Ivan Rilski"
Sofia, Bulgaria
- Umhat
Stara Zagora, Bulgaria
- University of British Columbia, Dept. of Dermatology and Skin Science
Vancouver, British Columbia, Canada
- Revmatologicky Ustav
Prague, Czechia
- Charite-Universitatsmedizin
Berlin, Germany
- University Hospital Erlangen Nuremberg
Erlangen, Germany
- University Medical Center Goettingen
Göttingen, Germany
- University of Debrecen
Debrecen, Hungary
- University Hospital Policlinico-Vittorio Emanuele
Catania, Italy
- Fondazione Policlinico Universitario A.Gemelli-Irccs
Roma, Italy
- Gunma University Hospital
Gunma, Japan
- Hokkaido University Hospital
Hokkaido, Japan
- Yokohama City University Hospital
Kanagawa, Japan
- Kyoto University Hospital
Kyoto, Japan
- Tohoku University Hospital
Miyagi, Japan
- Osaka University Hospital
Osaka, Japan
- Keio University Hospital
Tokyo, Japan
- Nippon Medical School Hospital
Tokyo, Japan
- Wakayama Medical Hospital
Wakayama, Japan
- Klimed
Bialystok, Poland
- Kliniczny Szpital Wojewodzki Nr 1. Im Fryderyka Chopina Klinika Dermatologii
Rzeszów, Poland
- Klimed
Łomża, Poland
- Inha University Hospital
Incheon, South Korea
- Hanyang University Hospital
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Seoul St. Mary'S Hospital
Seoul, South Korea
- Vall D'Hebron General Hospital
Barcelona, Spain
- Hospital 12 Octubre
Madrid, Spain
- Karolinska University Hospital, Rheumatology Clinic
Stockholm, Sweden
- King'S College Hospital Nhs Foundation Trust
London, United Kingdom
- Honorhealth Neurology
Phoenix, Arizona, United States
- Mayo Clinic
Scottsdale, Arizona, United States
- Attune Health Center
Beverly Hills, California, United States
- Ucla Division of Rheumatology
Los Angeles, California, United States
- Denver Arthritis Clinic
Denver, Colorado, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Mayo Clinic
Jacksonville, Florida, United States
- University of Miami
Miami, Florida, United States
- University of South Florida
Tampa, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Dec 2018
- Primary completion
- 31 Mar 2021
- Completion
- 5 Oct 2021
- Last update posted
- 16 Aug 2022
- Registered enrollment
- 176
- Registry id
- NCT03813160
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.